Amazon Web Services (AMZN) has been increasing its partnerships with health companies to advance AI capabilities in healthcare. In the past year, that has included names like GE HealthCare (GEHC) and General Catalyst.
This week, the company announced a new partnership with Memorial Sloan Kettering (MSK) to help develop cancer patient treatments and track cancer research.
“The goal will be to build a high-quality, up-to-date longitudinal data resource for cancer research at MSK, as well as serve as a source for validating and improving cancer research with partners,” the companies said in a statement.
“With this, MSK researchers and providers can better track how a patient’s cancer changes over time using computable disease trajectories. Combined with advanced tumor and clinical response predictions, this data-driven approach can help uncover new insights, personalize treatments, and improve patient care,” the statement said.
At close: February 24 at 4:00:00 PM EST
In an interview with Yahoo Finance, MSK’s chief strategy officer Dr. Anaeze Offodile II said that while the technology isn’t perfect yet, building the model together is the only way to evaluate AI in healthcare.
“There’s a lot of attention, a lot of hype, on AI, but I’ll say it’s still a nascent field. There’s been no clear transformational or canonical discovery in AI, yet,” Offodile said.
“Lots of potential. Lots of stars being born and funded. With humility, we certainly don’t want to overstate what we can accomplish, but I think we have maximized the odds of success by having these two enterprises thoughtfully engage,” he said.
This isn’t the first relationship AWS is building in healthcare delivery. The company has also been one of GEHC’s partners for years, and last year unveiled X-ray and MRI models. But even that partnership is under the scope of a research project, with the GEHC emphasizing that the technology is still not ready for full-scale deployment.
“In November, we featured AWS as one of our key industry collaborators at our Investor Day as we continue to lean into our AI and cloud-first innovations to develop cutting edge foundation models,” GE said in a statement to Yahoo Finance.
Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee on social media platforms X, LinkedIn, and Bluesky @AnjKhem.
Click here for in-depth analysis of the latest health industry news and events impacting stock prices
link